Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Antimicrobial agents disclosed by Maruho

April 1, 1997

Millenium issued U.S. patents related to drug discovery

March 27, 1997

Cubist Pharmaceuticals and Genzyme enter compound library screening collaboration

March 26, 1997

Meiji Seika antibiotic scheduled for launch in Europe in 1998

March 26, 1997

Fujisawa obtains natural antifungal agent

March 26, 1997

Novel antibiotic isolated by Kitasato Institute and Chinese Academy of Medical Science

March 26, 1997

CytoTAb shows potential for use in the treatment of malaria

March 24, 1997

New formulation of podofilox receives FDA approval

March 24, 1997

First clinical trial results reported for MEDI-493

March 24, 1997

Freeze-dried fibrin-antibiotic complex for osteomyelitis

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.